Villaganas, Ruthelia S.
HRN: 21-29-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/29/2022
05/06/2022
IV
500mg
Q8H
Intra Abdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes